By immunofluorescence, FOXO1 was mostly restricted to the DAPI+ nuclei of CD31+ tumor endothelial cells in control and treated mice (Fig 7E), attributable to the rapid degradation of cytoplasmic FOXO1. Here, FOXO1 is linked to neoplasm.